These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3474668)

  • 21. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC; Harlan JM; Adamson JW
    J Immunol; 1987 Jun; 138(12):4298-302. PubMed ID: 3495589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models.
    Gasparri A; Moro M; Curnis F; Sacchi A; Pagano S; Veglia F; Casorati G; Siccardi AG; Dellabona P; Corti A
    Cancer Res; 1999 Jun; 59(12):2917-23. PubMed ID: 10383155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-alpha and de novo mammalian angiogenesis.
    Norrby K
    Microvasc Res; 1996 Jul; 52(1):79-83. PubMed ID: 8812760
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety evaluation of biotechnology derived products.
    Galbraith WM
    Prog Clin Biol Res; 1987; 235():3-14. PubMed ID: 3474670
    [No Abstract]   [Full Text] [Related]  

  • 25. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
    Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaginary hazards?
    Miller HI; Huttner SL
    Nature; 1991 Sep; 353(6341):204. PubMed ID: 1896066
    [No Abstract]   [Full Text] [Related]  

  • 27. New apoptosis drugs face critical test.
    Garber K
    Nat Biotechnol; 2005 Apr; 23(4):409-11. PubMed ID: 15815657
    [No Abstract]   [Full Text] [Related]  

  • 28. Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors.
    Loskog A; Ninalga C; Tötterman TH
    Cancer Immunol Immunother; 2006 May; 55(5):588-97. PubMed ID: 16175400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotechnology. Yeast engineered to produce sugared human proteins.
    Service RF
    Science; 2003 Aug; 301(5637):1171. PubMed ID: 12947173
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicology. Panel urges further study of biotech corn.
    Kaiser J
    Science; 2000 Dec; 290(5498):1867. PubMed ID: 11187032
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetically engineered organic food?
    Hoyle R
    Nat Biotechnol; 1998 Mar; 16(3):214. PubMed ID: 9527990
    [No Abstract]   [Full Text] [Related]  

  • 35. Problems presented by animal toxicity studies.
    Harada Y
    Prog Clin Biol Res; 1987; 235():127-42. PubMed ID: 3110789
    [No Abstract]   [Full Text] [Related]  

  • 36. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.
    Ruddle NH
    J Immunol; 1986 Mar; 136(6):2335-6. PubMed ID: 3485146
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tumor necrosis factor].
    Aderka D; Levo Y
    Harefuah; 1987 Apr; 112(7):357-9. PubMed ID: 3497850
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterisation of engineered proteins: some critical reflections.
    Dittmar KE; Woolley P
    Bioessays; 1990 Jan; 12(1):47-9. PubMed ID: 2182004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of a tumor necrosis factor-like activity by Nocardia rubra cell wall skeleton.
    Izumi S; Hirai O; Hayashi K; Konishi Y; Okuhara M; Kohsaka M; Aoki H; Yamamura Y
    Cancer Res; 1987 Apr; 47(7):1785-92. PubMed ID: 3815373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interaction of anti-TNF-alpha monoclonal antibodies E7H2 with mutant and hybrid proteins].
    Shingarova LN; Sagaĭdak LN; Berkova HP; Korobko VG
    Bioorg Khim; 1997 May; 23(5):428-33. PubMed ID: 9290052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.